Legal & General Group PLC Y M Abs Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 37,695 shares of YMAB stock, worth $307,214. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,695
Previous 37,695 -0.0%
Holding current value
$307,214
Previous $494,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$9.95 - $15.39 $11,084 - $17,144
1,114 Added 3.05%
37,695 $494,000
Q2 2024

Aug 14, 2024
BUY
$11.6 - $17.25 $385,932 - $573,907
33,270 Added 1004.83%
36,581 $441,000
Q1 2024

May 14, 2024
SELL
$6.57 - $18.69 $2,358 - $6,709
-359 Reduced 9.78%
3,311 $53,000
Q4 2023

Feb 15, 2024
BUY
$4.88 - $7.42 $1,459 - $2,218
299 Added 8.87%
3,670 $25,000
Q3 2023

Nov 14, 2023
SELL
$4.86 - $7.23 $2,673 - $3,976
-550 Reduced 14.03%
3,371 $18,000
Q2 2023

Aug 14, 2023
SELL
$5.68 - $10.34 $2,891 - $5,263
-509 Reduced 11.49%
3,921 $26,000
Q1 2023

May 15, 2023
SELL
$2.83 - $5.11 $31,257 - $56,439
-11,045 Reduced 71.37%
4,430 $22,000
Q3 2022

Nov 14, 2022
SELL
$13.96 - $19.67 $83,662 - $117,882
-5,993 Reduced 27.92%
15,475 $223,000
Q2 2022

Aug 22, 2022
BUY
$8.22 - $15.13 $94,275 - $173,525
11,469 Added 114.7%
21,468 $325,000
Q4 2021

Feb 14, 2022
BUY
$15.51 - $29.31 $1,318 - $2,491
85 Added 0.86%
9,999 $162,000
Q3 2021

Nov 15, 2021
BUY
$27.47 - $37.31 $139,630 - $189,646
5,083 Added 105.22%
9,914 $282,000
Q2 2021

Aug 12, 2021
BUY
$25.45 - $37.64 $7,711 - $11,404
303 Added 6.69%
4,831 $163,000
Q1 2021

May 17, 2021
BUY
$29.16 - $51.96 $6,619 - $11,794
227 Added 5.28%
4,528 $137,000
Q4 2020

Feb 12, 2021
SELL
$37.86 - $54.26 $1,552 - $2,224
-41 Reduced 0.94%
4,301 $212,000
Q3 2020

Nov 13, 2020
SELL
$35.13 - $43.62 $46,266 - $57,447
-1,317 Reduced 23.27%
4,342 $166,000
Q2 2020

Aug 14, 2020
BUY
$23.66 - $49.53 $26,901 - $56,315
1,137 Added 25.14%
5,659 $244,000
Q1 2020

May 14, 2020
SELL
$14.39 - $35.8 $15,498 - $38,556
-1,077 Reduced 19.24%
4,522 $118,000
Q4 2019

Feb 13, 2020
BUY
$23.81 - $33.78 $52,548 - $74,552
2,207 Added 65.06%
5,599 $175,000
Q2 2019

Aug 14, 2019
BUY
$19.51 - $28.31 $45,224 - $65,622
2,318 Added 215.83%
3,392 $78,000
Q4 2018

Feb 15, 2019
BUY
$15.41 - $28.92 $16,550 - $31,060
1,074 New
1,074 $22,000

Others Institutions Holding YMAB

# of Institutions
106
Shares Held
24.5M
Call Options Held
40.3K
Put Options Held
400
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $356M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email